Orfadin Interactions
There are 226 drugs known to interact with Orfadin (nitisinone), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 8 are major, 216 are moderate, and 2 are minor.
- View all 226 medications that may interact with Orfadin
- View Orfadin alcohol/food interactions (1)
- View Orfadin disease interactions (1)
Most frequently checked interactions
View interaction reports for Orfadin (nitisinone) and the medicines listed below.
- Actemra (tocilizumab)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Corlanor (ivabradine)
- Crixivan (indinavir)
- Enbrel (etanercept)
- Esbriet (pirfenidone)
- Fasenra (benralizumab)
- Feiba (anti-inhibitor coagulant complex)
- Hemlibra (emicizumab)
- Isentress (raltegravir)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Matulane (procarbazine)
- Norvir (ritonavir)
- NovoSeven RT (coagulation factor viia)
- Ofev (nintedanib)
- Onpattro (patisiran)
- Prograf (tacrolimus)
- Pulmozyme (dornase alfa)
- Repatha (evolocumab)
- Rescriptor (delavirdine)
- Sensipar (cinacalcet)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Sucraid (sacrosidase)
- Tecentriq (atezolizumab)
- Tecfidera (dimethyl fumarate)
- Videx (didanosine)
- Viread (tenofovir)
Orfadin alcohol/food interactions
There is 1 alcohol/food interaction with Orfadin (nitisinone).
Orfadin disease interactions
There is 1 disease interaction with Orfadin (nitisinone) which include:
More about Orfadin (nitisinone)
- Orfadin consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.